Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer

<p>We sought information worldwide on mortality according to assigned treatment in all randomized trials that began before 1985 of adjuvant tamoxifen or cytotoxic therapy for early breast cancer (with or without regional lymph-node involvement). Coverage was reasonably complete for most countr...

Detaylı Bibliyografya
Yazar:	Early Breast Cancer Trialists' Collaborative Group
Diğer Yazarlar:	Henderson, I
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Massachusetts Medical Society 1988

Benzer Materyaller

Tamoxifen for early breast cancer: an overview of the randomised trials
Yazar:: Early Breast Cancer Trialists' Collaborative Group
Baskı/Yayın Bilgisi: (1998)

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
Yazar:: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Baskı/Yayın Bilgisi: (2011)

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
Yazar:: Early Breast Cancer Trialists’ Collaborative Group
Baskı/Yayın Bilgisi: (2017)

Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials
Yazar:: Early Breast Cancer Trialists' Collaborative Group
Baskı/Yayın Bilgisi: (1995)

Polychemotherapy for early breast cancer: an overview of the randomised trials
Yazar:: Early Breast Cancer Trialists' Collaborative Group
Baskı/Yayın Bilgisi: (1998)

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
Yazar:: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Baskı/Yayın Bilgisi: (2005)

Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials
Yazar:: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Baskı/Yayın Bilgisi: (2008)

Ovarian ablation in early breast cancer: overview of the randomised trials
Yazar:: Early Breast Cancer Trialists' Collaborative Group
Baskı/Yayın Bilgisi: (1996)

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: patient level meta-analysis of 7,030 women in four randomised trials
Yazar:: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Baskı/Yayın Bilgisi: (2022)

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
Yazar:: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Baskı/Yayın Bilgisi: (2005)

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
Yazar:: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Baskı/Yayın Bilgisi: (2014)

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
Yazar:: Early Breast Cancer Trialists’ Collaborative group (EBCTCG)
Baskı/Yayın Bilgisi: (2021)

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women
Yazar:: Early Breast Cancer Trialist's Collaborative Group
Baskı/Yayın Bilgisi: (1992)

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
Yazar:: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Baskı/Yayın Bilgisi: (2011)

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials
Yazar:: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Baskı/Yayın Bilgisi: (2011)

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast
Yazar:: Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
Baskı/Yayın Bilgisi: (2010)

EFFECTS OF ADJUVANT TAMOXIFEN AND OF CYTOTOXIC THERAPY ON MORTALITY IN EARLY BREAST-CANCER - AN OVERVIEW OF 61 RANDOMIZED TRIALS AMONG 28,896 WOMEN
Yazar:: Peto, R
Baskı/Yayın Bilgisi: (1989)

[Duration of adjuvant treatment with tamoxifen in patients with resectable breast cancer]
Yazar:: Davies, C, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

WITHDRAWN: Tamoxifen for early breast cancer.
Yazar:: Clarke, M
Baskı/Yayın Bilgisi: (2008)

Nordamnacanthal potentiates the cytotoxic effects of tamoxifen in human breast cancer cells
Yazar:: Mohamed Alitheen, Noorjahan Banu, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival.
Yazar:: Gelber, R, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years
Yazar:: Pan, H, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Tamoxifen in breast conservation therapy.
Yazar:: Lee, K, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Tamoxifen therapy for patients with breast cancer - Authors' reply.
Yazar:: Davies, C, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen
Yazar:: Dowsett, M, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Variation in use of adjuvant tamoxifen.
Yazar:: Davies, C, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Dosage-dependent reduction of macular pigment optical density in female breast cancer patients receiving tamoxifen adjuvant therapy
Yazar:: Lim, I-Liang, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Tamoxifen for early breast cancer: better late than never.
Yazar:: Gray, R, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Early breast cancer: How long should tamoxifen continue?
Yazar:: Davies, C, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Early breast cancer: How long should tamoxifen continue?
Yazar:: Davies, C, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

THE EBCTCG OVERVIEW OF ADJUVANT THERAPY OF BREAST-CANCER
Yazar:: Gray, R, ve diğerleri
Baskı/Yayın Bilgisi: (1994)

Meta-analyses of adjuvant therapies for women with early breast cancer: the Early Breast Cancer Trialists' Collaborative Group overview.
Yazar:: Clarke, M
Baskı/Yayın Bilgisi: (2006)

Which adjuvant endocrine therapy for ER-positive non-metastatic breast cancer? EBCTCG-2000 update: Tamoxifen, castration, LHRH-agonists
Yazar:: Davies, C, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Cost-Effectiveness of Adjuvant Trastuzumab Therapy for Early Breast Cancer in Asia: A Systematic Review
Yazar:: Abdul Rafar, Noor Razilah, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality
Yazar:: Kerr, AJ, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study
Yazar:: O'Connell, R, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

The EBCTCG overview of adjuvant therapy of breast cancer. What are the implications for future studies? Early Breast Cancer Trialists' Collaborative Group.
Yazar:: Gray, R, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

The benefits and harms of breast cancer screening: an independent review.
Yazar:: Independent UK Panel on Breast Cancer Screening
Baskı/Yayın Bilgisi: (2012)

Adjuvant treatment for breast cancer
Yazar:: Flatley, M, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Switching to exemestane after 2-3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen.
Yazar:: Davies, C
Baskı/Yayın Bilgisi: (2004)